Ultragenyx Pharmaceutical’s (RARE) Buy Rating Reiterated at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Ultragenyx Pharmaceutical (NASDAQ:RARE – Free Report) in a report released on Friday morning,Benzinga reports. HC Wainwright currently has a $95.00 target price on the biopharmaceutical company’s stock. Several other analysts have also recently commented on the stock. Wells Fargo & Company raised their target price on […]
HC Wainwright reiterated their buy rating on shares of Ultragenyx Pharmaceutical (NASDAQ:RARE – Free Report) in a report released on Friday morning,Benzinga reports. HC Wainwright currently has a $95.00 target price on the biopharmaceutical company’s stock. Several other analysts have also recently commented on the stock. Wells Fargo & Company raised their target price on […]
